- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03221868
Effects of a Physical Exercise Program Among Diabetic Women Users of the National Health System
August 25, 2017 updated by: MARLOS RODRIGUES DOMINGUES, Federal University of Pelotas
Effects of a Physical Exercise Program Among Diabetic Women Users of the National Health System: a Randomized Clinical Trial
The study aims at evaluating the effects of an intervention among diabetic women (40 years or older) who belong to the Basic Health Units System (Brazilian public health system).
The novelty of this project is that the intervention is low cost and demands very little from the health system in terms of structure, facilities and personnel.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The objective of this project is to evaluate the effect of a physical exercise program on the biochemical profile of type 2 diabetic women users of Basic Health Units (BHU) in the urban area of the city of Pelotas (Brazil).
This is a randomized clinical trial, where two BHU's of the 14 eligible for the study will be drawn for inclusion in the study.
Only those units with more than 100 registered diabetic patients are eligible, they also are not linked to educational institutions and do not present Physical activity projects.
Four Basic Health Units (BHU) of the municipality of Pelotas (Brazil) were randomized, two for the intervention group and two for the control group.
The intervention group will perform circuit-like physical exercises three times a week and the control will receive counseling to practice physical activity and meetings every 15 days with the womens to carry out walks.
The program lasted 12 weeks, with three weekly sessions and presented four distinct sequences containing 10 exercises each, which were performed and circuit form and modified every three weeks.
In the first week of the intervention, the women performed a passage in the circuit and with each new week a passage was increased, until the number of three passes was reached (number of passages kept fixed until the end of the intervention).
Each exercise initially had a duration of 30 seconds, with a duration of 10 seconds added every three weeks up to a maximum of 60 seconds; The interval of 30 seconds between exercises was kept fixed throughout the intervention.
The intensity was controlled by the subjective perception of effort.
Mainly blood chemistry will be measured and evaluated.Possible confounding factors to be controlled: age, skin color, schooling, family income, weight, Body Mass Index (BMI), alcohol consumption, smoking, waist circumference, time to diagnose the disease, use of Medicines for diabetes and eating habits.
The information will be collected at the baseline, at the eighth week and at the end of the study.
Descriptive analyzes of the data will be performed initially, the associations will be tested by correlation, t-test and ANOVA for repeated measures.
For comparisons of categorical variables, Chi-square tests will be used for heterogeneity or linear trend.
The multivariate analysis will be run through logistic regression.
The analyzes will be performed by intention to treat and by adherence, and the level of significance accepted for the study will be 5%.
This study will seek to fill gaps in the knowledge about intervention studies in BHU's in order to identify whether physical exercise interventions with proper planning and orientation can promote improvements in the severity of the disease in diabetic women.
Study Type
Interventional
Enrollment (Actual)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rio Grande do Sul
-
Pelotas, Rio Grande do Sul, Brazil, 96055-630
- Physical Education School of the Federal University of Pelotas
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- females;
- type 2 diabetic;
- diagnosed for more than one year;
- BMI ≥25 kg / m²;
- age between 40 and 60 years.
Exclusion Criteria:
- BMI ≥ 40 kg / m²;
- history of stroke;
- neuropathy or severe retinopathy;
- any serious medical condition that prevents the participant to exercise safely;
- history of severe physical disability
- history of acute myocardial infarction in the last six months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Physical exercise intervention
Exercise group.
Physical exercise intervention with sessions carried out as circuit-training, three times a week for 12 weeks to improve physical fitness and metabolic control.
The sessions will last between 10 and 45 minutes.
|
An exercise-based program following a 12-week periodization using mostly circuit-like activities.
|
|
Active Comparator: Control
Control group consisting of women who underwent the same measurements for future comparisons and were assigned to receive information about health and counseling to practice of physical activity.
|
Counseling to practice physical activity and meetings every 15 days with women to conduct group walks.
Booklet with walking schedule and for registering sessions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in HbA1c
Time Frame: Measured at baseline, and the end of intervention, 12th week
|
- Glycated hemoglobin - %
|
Measured at baseline, and the end of intervention, 12th week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Glucose
Time Frame: Measured at baseline, and the end of intervention, 12th week
|
Fasting glucose - mg/dl
|
Measured at baseline, and the end of intervention, 12th week
|
|
Change in Insulin
Time Frame: Measured at baseline, and the end of intervention, 12th week
|
Fasting insulin - μI/ml
|
Measured at baseline, and the end of intervention, 12th week
|
|
Change in BP
Time Frame: Measured at baseline, and the end of intervention, 12th week
|
- Blood pressure - mm/hg measured with an automated equipment;
|
Measured at baseline, and the end of intervention, 12th week
|
|
Change in Insulin resistance
Time Frame: Measured at baseline, and the end of intervention, 12th week
|
Insulin resistance - Insulin (μI/L) X Fasting Glycemia (mg/dl)/405
|
Measured at baseline, and the end of intervention, 12th week
|
|
Change in Triglycerides
Time Frame: Measured at baseline, and the end of intervention, 12th week
|
Triglycerides - mg/dl
|
Measured at baseline, and the end of intervention, 12th week
|
|
Change in Cholesterol
Time Frame: Measured at baseline, and the end of intervention, 12th week
|
Total cholesterol and subfractions - mg/dl
|
Measured at baseline, and the end of intervention, 12th week
|
|
Change in CRP
Time Frame: Measured at baseline, and the end of intervention, 12th week
|
C-reactive protein - mg/l
|
Measured at baseline, and the end of intervention, 12th week
|
|
Change in CRF
Time Frame: Measured at baseline, and the end of intervention, 12th week
|
- Cardiorespiratory fitness - calculated based on the distance covered during the 6-minute walking test;
|
Measured at baseline, and the end of intervention, 12th week
|
|
Change in LLS
Time Frame: Measured at baseline, and the end of intervention, 12th week
|
- Lower limb strength - number of repetitions performed during the 30-Second Chair Stand Test;
|
Measured at baseline, and the end of intervention, 12th week
|
|
Change in QoL
Time Frame: Measured at baseline, and the end of intervention, 12th week
|
- Quality of life (SF-36) - sum of the scores of the scale.
|
Measured at baseline, and the end of intervention, 12th week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: MARLOS R DOMINGUES, PhD, Postgraduate Program in Physical Education, Federal University of Pelotas
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2016
Primary Completion (Actual)
March 1, 2017
Study Completion (Actual)
July 1, 2017
Study Registration Dates
First Submitted
December 27, 2016
First Submitted That Met QC Criteria
July 15, 2017
First Posted (Actual)
July 19, 2017
Study Record Updates
Last Update Posted (Actual)
August 28, 2017
Last Update Submitted That Met QC Criteria
August 25, 2017
Last Verified
August 1, 2017
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- diabetes7005
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
State University of New York at BuffaloMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Medtronic MiniMed, Inc.RecruitingType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States, Australia, New Zealand
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
Clinical Trials on Exercise group
-
University of ReginaUniversity of Saskatchewan; Saskatchewan Health Research Foundation; First Steps...RecruitingMultiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveCanada
-
University of Colorado, DenverTemple University; Virginia Commonwealth University; University of Colorado,... and other collaboratorsCompleted
-
Shanghai Pudong HospitalUnknown
-
University of OxfordOxford Brookes UniversityRecruitingOverweight/Obesity, AdolescentUnited Kingdom
-
Istanbul University - CerrahpasaRecruitingLateral EpicondylitisTurkey
-
Hasselt UniversityRecruitingGestational Hypertension | Cardiovascular Pregnancy ComplicationBelgium
-
Tel Aviv UniversityHadassah Medical OrganizationWithdrawnBreast Cancer | Colon CancerIsrael
-
Marmara UniversityRecruiting
-
International Hellenic UniversityCompleted
-
Muğla Sıtkı Koçman UniversityRecruitingChronic Neck PainTurkey